P-glycoprotein efflux and other factors limit brain amyloid beta reduction by beta-site amyloid precursor protein-cleaving enzyme 1 inhibitors in mice.

MLA

Meredith, Jere E., Jr, et al. “P-Glycoprotein Efflux and Other Factors Limit Brain Amyloid Beta Reduction by Beta-Site Amyloid Precursor Protein-Cleaving Enzyme 1 Inhibitors in Mice.” The Journal of Pharmacology and Experimental Therapeutics, vol. 326, no. 2, Aug. 2008, pp. 502–13. EBSCOhost, https://doi.org/10.1124/jpet.108.138974.

APA

Meredith, J. E., Jr, Thompson, L. A., Toyn, J. H., Marcin, L., Barten, D. M., Marcinkeviciene, J., Kopcho, L., Kim, Y., Lin, A., Guss, V., Burton, C., Iben, L., Polson, C., Cantone, J., Ford, M., Drexler, D., Fiedler, T., Lentz, K. A., Grace, J. E., Jr, … Albright, C. F. (2008). P-glycoprotein efflux and other factors limit brain amyloid beta reduction by beta-site amyloid precursor protein-cleaving enzyme 1 inhibitors in mice. The Journal of Pharmacology and Experimental Therapeutics, 326(2), 502–513. https://doi.org/10.1124/jpet.108.138974

Chicago

Meredith, Jere E, Jr, Lorin A Thompson, Jeremy H Toyn, Lawrence Marcin, Donna M Barten, Jovita Marcinkeviciene, Lisa Kopcho, et al. 2008. “P-Glycoprotein Efflux and Other Factors Limit Brain Amyloid Beta Reduction by Beta-Site Amyloid Precursor Protein-Cleaving Enzyme 1 Inhibitors in Mice.” The Journal of Pharmacology and Experimental Therapeutics 326 (2): 502–13. doi:10.1124/jpet.108.138974.